Comments on: Changing the game in pharma patent strategy http://www.thinkipstrategy.com/ipthinktank/765/changing-the-game-in-pharma-patent-strategy/ Trusted advisors to the world's most innovative companies Mon, 16 Jan 2012 09:10:00 +0000 hourly 1 http://wordpress.org/?v=3.2.1 By: Leighton http://www.thinkipstrategy.com/ipthinktank/765/changing-the-game-in-pharma-patent-strategy/comment-page-1/#comment-1447 Leighton Tue, 19 Jan 2010 22:57:21 +0000 http://localhost:100/thinkipstrategy/?p=765#comment-1447 <p>Wow!! is all I can say.  It seems to me to fly in the face of basic chemistry, but then I guess that's why we have experts in court.  I'm still not convinced though and can see why Navinta thought that this was just another evergreening attempt by an innovator.</p><p>GenericsWeb are just about to publish an article in our INNsight newsletter about Gatifloxacin, also commercially available in solution and also protected by an Orange-Book Listed hydrate patent. Apotex does not appear to have been sued in respect of this patent upon filing the PIV for this product, although they were sued for a different, formulation patent.</p><p>Still digging on this one but I wonder if this would change Allergan's strategy in the US and how??</p> Wow!! is all I can say.  It seems to me to fly in the face of basic chemistry, but then I guess that’s why we have experts in court.  I’m still not convinced though and can see why Navinta thought that this was just another evergreening attempt by an innovator.

GenericsWeb are just about to publish an article in our INNsight newsletter about Gatifloxacin, also commercially available in solution and also protected by an Orange-Book Listed hydrate patent. Apotex does not appear to have been sued in respect of this patent upon filing the PIV for this product, although they were sued for a different, formulation patent.

Still digging on this one but I wonder if this would change Allergan’s strategy in the US and how??

]]> By: Leighton http://www.thinkipstrategy.com/ipthinktank/765/changing-the-game-in-pharma-patent-strategy/comment-page-1/#comment-2118 Leighton Tue, 19 Jan 2010 22:57:00 +0000 http://localhost:100/thinkipstrategy/?p=765#comment-2118 Wow!! is all I can say.  It seems to me to fly in the face of basic chemistry, but then I guess that's why we have experts in court.  I'm still not convinced though and can see why Navinta thought that this was just another evergreening attempt by an innovator.GenericsWeb are just about to publish an article in our INNsight newsletter about Gatifloxacin, also commercially available in solution and also protected by an Orange-Book Listed hydrate patent. Apotex does not appear to have been sued in respect of this patent upon filing the PIV for this product, although they were sued for a different, formulation patent.Still digging on this one but I wonder if this would change Allergan's strategy in the US and how?? Wow!! is all I can say.  It seems to me to fly in the face of basic chemistry, but then I guess that’s why we have experts in court.  I’m still not convinced though and can see why Navinta thought that this was just another evergreening attempt by an innovator.GenericsWeb are just about to publish an article in our INNsight newsletter about Gatifloxacin, also commercially available in solution and also protected by an Orange-Book Listed hydrate patent. Apotex does not appear to have been sued in respect of this patent upon filing the PIV for this product, although they were sued for a different, formulation patent.Still digging on this one but I wonder if this would change Allergan’s strategy in the US and how??

]]>